# Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

> **NCT00004102** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** FOLFOX regimen
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00004102
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** 2001-11
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004102, "Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*